Answers are grounded in this paper and cite their sources.
Analysis identifies high-risk drug classes and establishes baseline risk estimates for drug safety monitoring.
This analysis establishes baseline class-level risk estimates in a developing pharmacovigilance environment, identifies disproportionately high-risk drug classes, and supports the robustness of PRR and ROR as complementary screening tools for regional drug safety monitoring.
No takes yet. Share an insight, caveat, or question.
Umer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: